Stock 300642 TELLGEN CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Tellgen Corporation

Equities

300642

CNE100002P42

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
14.39 CNY +0.21% Intraday chart for Tellgen Corporation +11.03% -18.47%
Apr. 22 Tellgen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 01 Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on February 6, 2024. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3,439 3,739 5,208 5,197 3,385 2,879
Enterprise Value (EV) 1 2,801 3,075 4,625 4,731 2,847 2,395
P/E ratio 24.1 x 23.7 x 43.1 x 32.4 x 27.1 x 32.2 x
Yield 0.79% 0.97% 0.7% 0.79% 0.96% 0.85%
Capitalization / Revenue 9.43 x 8.47 x 10.6 x 7.94 x 4.73 x 5.3 x
EV / Revenue 7.68 x 6.97 x 9.45 x 7.23 x 3.98 x 4.41 x
EV / EBITDA 16.7 x 15.3 x 28.7 x 24.7 x 18.5 x 19.5 x
EV / FCF -229 x 23.2 x -105 x -147 x 42 x 52.3 x
FCF Yield -0.44% 4.32% -0.95% -0.68% 2.38% 1.91%
Price to Book 3.36 x 3.2 x 4.11 x 3.73 x 2.28 x 1.88 x
Nbr of stocks (in thousands) 163,518 163,471 163,313 163,904 162,798 163,089
Reference price 2 21.03 22.87 31.89 31.71 20.79 17.65
Announcement Date 4/24/19 4/24/20 4/23/21 4/22/22 4/21/23 4/22/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 364.8 441.5 489.6 654.6 716 542.8
EBITDA 1 168.1 201.6 161.1 191.6 154 122.9
EBIT 1 136 158.8 106.9 126.2 80.33 51.53
Operating Margin 37.27% 35.98% 21.83% 19.28% 11.22% 9.49%
Earnings before Tax (EBT) 1 165.4 181.1 130.4 178.2 130.7 87.48
Net income 1 141.7 157 120.6 161.1 124.8 89.4
Net margin 38.84% 35.57% 24.62% 24.61% 17.43% 16.47%
EPS 2 0.8728 0.9667 0.7400 0.9800 0.7670 0.5480
Free Cash Flow 1 -12.21 132.7 -44.16 -32.27 67.78 45.78
FCF margin -3.35% 30.06% -9.02% -4.93% 9.47% 8.43%
FCF Conversion (EBITDA) - 65.83% - - 44.01% 37.25%
FCF Conversion (Net income) - 84.51% - - 54.33% 51.21%
Dividend per Share 2 0.1667 0.2222 0.2222 0.2500 0.2000 0.1500
Announcement Date 4/24/19 4/24/20 4/23/21 4/22/22 4/21/23 4/22/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 200.4 145.1 175.5 197.8 197.5 121.8 154.2 125.2
EBITDA - - - - - - - -
EBIT 1 61.52 5.477 40.95 48.02 36.98 10.1 15.57 4.687
Operating Margin 30.7% 3.77% 23.33% 24.27% 18.72% 8.29% 10.1% 3.74%
Earnings before Tax (EBT) - - - - - - - -
Net income - - - - - - - -
Net margin - - - - - - - -
EPS 2 -0.1823 0.0320 0.2300 0.2800 0.2300 0.0683 0.1451 0.0493
Dividend per Share - - - - - - - -
Announcement Date 4/22/22 4/22/22 8/19/22 10/28/22 4/21/23 4/21/23 8/18/23 10/24/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 638 664 582 467 538 483
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -12.2 133 -44.2 -32.3 67.8 45.8
ROE (net income / shareholders' equity) 14.8% 14.3% 9.9% 12.1% 8.6% 5.62%
ROA (Net income/ Total Assets) 8.34% 8.45% 5.1% 5.5% 3.17% 1.93%
Assets 1 1,699 1,858 2,363 2,931 3,931 4,642
Book Value Per Share 2 6.260 7.150 7.760 8.500 9.110 9.380
Cash Flow per Share 2 3.090 2.090 1.920 1.140 1.510 2.390
Capex 1 145 100 79.5 114 66.9 101
Capex / Sales 39.61% 22.7% 16.23% 17.38% 9.34% 18.65%
Announcement Date 4/24/19 4/24/20 4/23/21 4/22/22 4/21/23 4/22/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
TELLGEN CORPORATION Stock Tellgen Corporation
-18.47% 323M
BIOMÉRIEUX Stock bioMérieux
-0.60% 12.95B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.84B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+1.82% 5.5B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.61B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+7.32% 4.61B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-47.68% 3.4B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.66B
VITROLIFE AB Stock Vitrolife AB
-14.59% 2.08B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+2.25% 1.79B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 300642 Stock
  4. Financials Tellgen Corporation